Phase 1 Clinical Trial of RHN-001 in Healthy Adult Volunteers

Clinical trial NCT05847218 · COMPLETED

Trial details

NCT number: NCT05847218
Sponsor: RH Nanopharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Tolerability Pharmacokinetics

Start date: 2023-03-09
Primary completion: 2023-03-19
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.